Subscribe

Medicover AB (publ) (MCOV-B.ST)

SEK229.00 +6.00 (+2.69%)
SE STO Healthcare Medical - Care Facilities
Address P.O. Box 5283 102 46
Stockholm, SE
CEO John Paul Stubbington
Website medicover.com
IPO 2017-05-23
ISIN SE0009778848

Explore sections of this company profile

Also trades on London Stock Exchange · 0RPS.L (SEK) Other OTC · MCVEF (USD) Other OTC · MCVEY (USD) Stockholm Stock Exchange · MCOV-B.ST (SEK)
Description

Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SEK229.00 +6.00 (+2.69%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
92.4K
Beta
1.51
Float Shares
131.82M
Free Float %
87.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.33% -5.38% +1.55% -5.38% -19.18% -7.17% -18.34% +12.01% -5.84% +200.46% +200.46%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
229.00
DCF (Unlevered) 123.29 -46.2%
DCF (Levered) 179.29 -21.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 60% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 3 0
Hold 2 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
2.13
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +13.7% ★ Q1'26: +8.0% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +363.6% ★ Q1'26: +15.4% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +5.3% Q1'26: +7.5% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +6.8% Q1'26: +7.2% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +6.3% Q1'26: +6.9% (vs Q1'25)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +0.5% Q1'26: +0.7% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    3.81× Q1'26: 3.56× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.51) × ERP
WACC = 66% × Ke + 34% × Kd (4.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 122.08 Current price: 229.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
6 Rev. Ana.
4 EPS Ana. 		Dec 2027
6 Rev. Ana.
5 EPS Ana. 		Dec 2028
6 Rev. Ana.
5 EPS Ana. 		Dec 2029
5 Rev. Ana.
1 EPS Ana. 		Dec 2030
3 Rev. Ana.
1 EPS Ana.
Revenue
580.20M
est: 576.66M (+0.6%)
671.60M
est: 678.93M (-1.1%)
844.40M
est: 847.67M (-0.4%)
997.80M
est: 963.18M (+3.6%)
1.38B
est: 1.34B (+2.8%)
1.51B
est: 1.54B (-1.7%)
1.75B
est: 167.14M (+944.9%)
2.09B
est: 2.07B (+1.2%)
2.38B
est: 2.39B (-0.6%)
2.63B
2.58B – 2.73B
+9.9% YoY
2.92B
2.85B – 3.04B
+11.0% YoY
3.24B
3.17B – 3.37B
+11.0% YoY
3.74B
3.67B – 3.89B
+15.6% YoY
4.15B
4.06B – 4.31B
+10.8% YoY
EBITDA
52.80M
est: 83.47M (-36.7%)
61.80M
est: 98.27M (-37.1%)
121.20M
est: 122.69M (-1.2%)
151.60M
est: 139.41M (+8.7%)
274.90M
est: 193.86M (+41.8%)
215.90M
est: 222.48M (-3.0%)
257.40M
est: 24.42M (+954.0%)
171.20M
est: 301.99M (-43.3%)
377.70M
est: 349.48M (+8.1%)
383.95M
377.24M – 398.68M
+9.9% YoY
426.15M
416.28M – 443.84M
+11.0% YoY
472.97M
463.28M – 491.90M
+11.0% YoY
546.85M
535.66M – 568.74M
+15.6% YoY
605.67M
593.27M – 629.91M
+10.8% YoY
EBIT
28.80M
est: 33.24M (-13.4%)
41.30M
est: 39.13M (+5.5%)
47.00M
est: 48.86M (-3.8%)
55.40M
est: 55.52M (-0.2%)
163.90M
est: 77.20M (+112.3%)
54.00M
est: 88.60M (-39.1%)
75.00M
est: 10.06M (+645.4%)
73.20M
est: 124.41M (-41.2%)
162.40M
est: 143.97M (+12.8%)
158.17M
155.41M – 164.24M
+9.9% YoY
175.56M
171.49M – 182.84M
+11.0% YoY
194.84M
190.86M – 202.64M
+11.0% YoY
225.28M
220.67M – 234.30M
+15.6% YoY
249.51M
244.40M – 259.50M
+10.8% YoY
Net Income
18.70M
est: 21.90M (-14.6%)
24.60M
est: 28.14M (-12.6%)
22.50M
est: 31.19M (-27.9%)
25.80M
est: 33.12M (-22.1%)
101.80M
est: 104.26M (-2.4%)
11.80M
est: 26.52M (-55.5%)
17.60M
est: 2.02M (+770.9%)
16.70M
est: 31.42M (-46.9%)
77.50M
est: 82.80M (-6.4%)
99.74M
98.66M – 100.83M
+20.5% YoY
129.73M
118.69M – 140.77M
+30.1% YoY
166.02M
160.39M – 171.66M
+28.0% YoY
193.58M
188.43M – 203.66M
+16.6% YoY
219.86M
214.01M – 231.30M
+13.6% YoY
SGA
35.70M
est: 38.89M (-8.2%)
37.90M
est: 45.79M (-17.2%)
42.30M
est: 57.17M (-26.0%)
40.00M
est: 64.96M (-38.4%)
54.70M
est: 90.34M (-39.4%)
64.20M
est: 103.67M (-38.1%)
297.10M
est: 15.49M (+1,818.6%)
93.70M
est: 191.48M (-51.1%)
395.00M
est: 221.59M (+78.3%)
243.45M
239.19M – 252.79M
+9.9% YoY
270.20M
263.95M – 281.42M
+11.0% YoY
299.89M
293.75M – 311.89M
+11.0% YoY
346.73M
339.64M – 360.61M
+15.6% YoY
384.02M
376.16M – 399.40M
+10.8% YoY
EPS
0.16
est: 0.15 (+9.7%)
0.18
est: 0.19 (-3.9%)
0.17
est: 0.21 (-18.1%)
0.18
est: 0.22 (-18.4%)
0.69
est: 0.69 (-0.6%)
0.08
est: 0.18 (-54.1%)
0.12
est: 0.01 (+788.9%)
0.11
est: 0.21 (-46.5%)
0.51
est: 0.54 (-5.8%)
0.66
0.65 – 0.67
+22.2% YoY
0.86
0.79 – 0.93
+30.3% YoY
1.10
1.06 – 1.14
+27.5% YoY
1.28
1.25 – 1.35
+16.6% YoY
1.46
1.42 – 1.53
+13.6% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 B 3/5 4/5 4/5 4/5 1/5 2/5 2/5
2026-05-08 B 3/5 4/5 4/5 4/5 1/5 2/5 2/5
2026-05-07 B 3/5 4/5 4/5 4/5 1/5 2/5 2/5
2026-05-06 B 3/5 4/5 4/5 4/5 1/5 2/5 2/5
2026-05-05 B 3/5 4/5 4/5 4/5 1/5 2/5 2/5
2026-05-04 B 3/5 4/5 4/5 4/5 1/5 2/5 2/5
2026-04-30 B 3/5 4/5 4/5 4/5 1/5 2/5 1/5
2026-04-29 B 3/5 4/5 4/5 4/5 1/5 2/5 1/5
2026-04-28 B 3/5 4/5 4/5 4/5 1/5 2/5 1/5
2026-04-27 B 3/5 4/5 4/5 4/5 1/5 2/5 1/5
2026-04-24 B 3/5 4/5 4/5 4/5 1/5 2/5 1/5
2026-04-23 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5
2026-04-22 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5
2026-04-21 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5
2026-04-20 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5
2026-04-17 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5
2026-04-16 B+ 3/5 4/5 4/5 5/5 1/5 2/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
286.48M
OE per share TTM
1.89
Owner's Yield
0.94%
Maintenance CapEx ratio
17.69%
Maint CapEx / Avg PPE
47.9%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 64 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares OMX Stockholm Capped UCITS ETF OM3X.DE 0.19% 411.3K 0.10%
2 iShares Ageing Population UCITS ETF AGED.L 0.15% 1.36M 0.40%
3 Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L 0.10% 3.53M 0.30%
4 iShares MSCI Europe Small-Cap ETF IEUS 0.10% 178.3K 0.41%
5 State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE 0.05% 384.9K 0.30%
6 iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ 0.04% 99.5K 0.83%
7 iShares MSCI EAFE Small-Cap ETF SCZ 0.04% 6.00M 0.40%
8 Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA 0.03% 106.6K 0.23%
9 Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE 0.03% 106.6K 0.23%
10 Vanguard FTSE All-World ex-US Small-Cap ETF VSS 0.03% 4.16M 0.06%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
3.5K
Shares Outstanding
150.98M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Fredrik Rågmark Executive Officer 3M male
John Paul Stubbington Chief Executive Officer 1M male
Hanna Bjellquist Head of Investor Relations — —
Jenny Brandt General Legal Counsel — female
Kamila Skorupinski Chief People Officer — female
Lukasz Krause Chief Digital Information Officer — male
Anand Patel Chief Financial Officer — male
Staffan Ternstrom Chief Operating Officer for Diagnostic Services — male
Andrew Vallance-Owen Chief Marketing Officer — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities